Top Pharma Conferences 2021 | Drug Delivery 2021 | Pharmaceutics Conferences | Novel Drug Delivery Systems Conferences | Meetings | Events | Zurich | Switerland | Europe | USA | Asia | 2021

Theme:

Drug Delivery 2021

Drug Delivery 2021

Conference Series LLC Ltd with great pride and honor announcing its “38th International Conference on Drug Discovery and Drug delivery system” which is going to be held online during March 17-18, 2021

Drug Delivery 2021 serves as a platform for the association between experts in the areas of Pharmaceutics, Drug Delivery, Drug Discovery, Biotechnology, and nanotechnology, Nano medicine around the world and sight in allocating some distinctive research and depicting studies on various advances in the fields related to the topics. This Drug Delivery Conference comprises a wide range of Keynote presentations, Oral talks, Poster presentations, Symposia, Workshops, Exhibitions, and Career development programs. The Drug Delivery event attributes a wide range of innovative drug delivery technologies that could prospect develop the delivery of various types of drugs, including proteins, peptides, oligonucleotides, biologics, and small molecules. The focus is to enhance and exchange the knowledge on cutting-edge technologies, research and development, new therapeutics, and summons in the field of pharmaceutical sciences and drug delivery.

Directors, CEO’s of Organizations
Associate Professors & Researchers
Generic drugs and Biosimilars, Lecturers
Analysis Associates
Scientists
Investigators
Young Research Fellows
Students
Pharmaceutical Industrialists
Businessmen
Pharmaceutical corporations
Medical technology companies
Formulation Scientists
Professors, Associate Professors & Assistant Professors
Chief Scientific Officers
Health care professionals

Drug Delivery 2021 provides you a great networking with peer network. Also, comprise, 10+ Keynote Speaker Session, 50+ speaker faculty over 2 full days sharing evidence Based, 5+ Workshops, 13 Interactive sessions, Mixture of Health care units and Academia Delegates, Networking provide a dedicated forum for the advancement, execution, and exchange of information about drug delivery . Professionals giving a chief specialized gathering to detailing and finding out about the most recent new era advancements created over the span of time alongside examining their applications. Generally acclaimed speakers, the most recent techniques, methodologies, and the most breakthrough updates in Drug Delivery are indications of this meeting.

Benefits of Attending Drug Delivery 2021 :

Exchange ideas and network with leading researchers, clinicians, and professionals from more than 40 countries.

Discuss quality initiatives that can be applied in the practice.

Discuss ways to collaborate in putting quality initiatives in place throughout the medicinal and pharmaceutical sciences.

Participants can gain direct access to a core audience of professionals and decision-makers and can increase visibility through branding and networking at the conference.

Learn and discuss key news and challenges with senior level speakers.

With presentations, panel discussions, roundtable discussions, and workshops, we cover every topic from top to bottom, from global macro issues to strategies to tactical issues

Track 1: Advanced Drug Delivery Systems

Advanced drug delivery systems (DDS) involves indubitable advantages for drug administration. Over the past three decades, new proposals have been recommended for the evolution of novel carriers for drug delivery. General concepts and emerging research in this field based on multidisciplinary proposals aimed to generate customized treatment for a broad range of highly universality diseases (e.g., cancer and diabetes). This review is made of two parts. The first part supplies an overview on currently available drug delivery technologies counting a brief history on the development of these systems and some of the research strategies applied. The second part supply information about the most advanced drug delivery devices using stimuli-responsive polymers.

Related Conferences : 18th World Pharma Congress | October 18-20, 2020 Warsaw, Poland | 4th International Conference on Drug Discovery and Advanced Drug Delivery Systems | October 18-19, 2020 at Warsaw, Poland | 18th Annual Pharmaceutical Chemical Analysis Congress | November 05-06, 2020 at Madrid, Spain | 9th Neuropharmacology Meeting | November 15-16, 2020 at Frankfurt, Germany | 3rd International Conference on Generics Drugs and Biosimilars | November 15-17, 2020, Frankfurt, Germany | 23rd International Pharmaceutical Biotechnology Conference | December 10-11, 2020 at Rome, Italy | 19th Pharmaceutical Sciences and Pharma Industry Conference February 25-26, 2020, Berlin, Germany | 12th European Biosimilars Congress | April 15-16, 2020 Berlin, Germany.

Track 2: Drug Targeting and Design

Target drug delivery system is a marked form of drug delivery system. The therapeutic response of a drug based upon the interaction of drug molecules with cell on cell membrane interconnected biological events at receptor sites in a concentration-dependent manner. Targeted drug delivery entail for selective and functional localization of pharmacologically active moiety at pre recognized (preselected) target in therapeutic concentration, while moderate its entrance to non-target normal cellular linings, thus reduce toxic effects and increase therapeutic index. Targeting of drugs to marked cells and tissues of the body without their becoming a part of systemic circulation is a tremendous novel idea. If a drug can be distribute in a form such that it reaches the receptor sites' inadequate concentration without interrupting in extraneous tissue cells.

Track 3: Drug Delivery Technologies

Pharmaceutical drug delivery technologies magnify drug absorption, efficacy, and patient experience. Taste maskers increase the commercial viability of your pharmaceutical products by neutralizing the strong, bitter tastes of certain oral medical formulations. “A growing number of companies are investing in technologies counting pen injectors , dry powder inhalers (DPIs), auto-injectors, nasal sprays, buccal films, intraocular implants, orally disintegrating tablets (ODT), and infusion pumps, numerous of which are draft for use with biologic drugs. The evolutions in these areas are a result of their proven technology, high dose efficacy, and their capability to offer magnify patient comfort and compliance.”

Track 4: Nanotechnology for better Drug Deliverability

Development and optimization of drug delivery approaches based in nanoparticles concern the early detection of cancer cells and/or specific tumor biomarkers, and the enhancement of the efficacy of the treatments applied. The usage of the ideal nano-drug delivery system is obstinate principally depend on the biophysical and biochemical properties of the targeted drugs being adopted for the treatment. Thus, using green nanoparticles for drug delivery can reduce the side-effects of the medications. Moreover, naturalizations in nanostructures' hydrophobicity, size, surface changes, and shape, can further magnify the bioactivity of these nanomaterials.

Track 5: Novel Drug Delivery

Novel Drug Delivery System (NDDS) developed in order to reduce drug degradation, drug adverse effect, and in order to maximize the drug bioavailability (amount of drug available at site targeted region). Site-specific drug delivery may be an active or passive process. Novel Drug Delivery System is a fusion of advanced skills and advanced dosage forms which are far fitter than conventional dosage forms. Evolution of an existing drug molecule from a conventional form to a novel delivery system can importantly improve its presentation in terms of patient acquiescence, security and potency. In the form of a Novel Drug Delivery System, a live drug molecule can get a new life.

Track 6: Drug Discovery and Development

Drug discovery is a versatile process by which new therapeutics are expanded. From initial target identification to late-stage clinical trials, a wide range of scientific personnel are required from across the biosciences and beyond. Biologists, protein scientists, medicinal chemists, pharmacologists, toxicologists and computational scientists all have key roles to play. This process is essential as it is the means by which new drugs, frequently with novel modes of action, become accessible to patients.

Track 7: Cellular Targeting and Intracellular Delivery

Targeted drug delivery to diseased tissues suggests keen benefits for therapy, such as enlarge potency and decrease side effects. The evolution of targeted drug delivery systems is handling by various drug design concerns, election of suitable cell culture models, and analytical tools for their observation. Targeting cells depend on the hardware encoding biological information. Whereas a practical benefit of the genetic code has not been announce until now, that of the peptide code constituted by antibody-based conceptions entered clinical trials and few products are already on the market. Recently, usage of the sugar code also became evident as a promising alternative.

Track 8: Anti-Cancer Drug Delivery Agents

Most explored approaches to developing cell-based Anti Cancer drug delivery systems (DDSs) are the encapsulation of the drug into the cells, cell surface modification, genetic modification of cells to secrete desired therapeutic proteins, and generating new biosynthetic systems. Tumor-tropism of mesenchymal stem cells (MSCs), as reveal in many studies, can be incorporate with expropriating engineering with anticancer genes to authorize their utilization in anticancer therapy. Furthermore, MSCs can be filled with nanoparticles (NPs), procure transport across the blood-brain barrier and accumulation of anticancer agent at the tumour site.

Track 9: Vaccine Drug Delivery Systems

Vaccines are determine as “preparations given to patients to induce immune reaction dominant to the making of antibodies (humoral) or cell-mediated reaction that will help in attacking infectious agents or non-infectious state such as malignancies”. Sub-unit vaccines though exceptionally selective and specific in reacting with antibodies often fail to show such reactions in circumstances such as shifts in epitopic identification centre of antibody and are poorly immunogenic. Active immunization is a process of enlarging retardation to infection whereby microorganisms or products of their pursuit act as an antigen and restore certain body cell produce a antibodies with particular defensive capacity.

Track 10: Peptides and Protein Drug Delivery

Peptide and Protein drug delivery system are known as Novel Drug Delivery System. Proteins and peptides are the most abundant components of biological cells. They exist functioning such as enzymes, hormones, structural element, and immunoglobulin. The twenty various naturally transpire amino acids join with each other by peptide bonds and construct polymers mentioned to peptides and proteins. Although the variance between peptides and proteins are peptide having less than 20 amino acids, having a molecular weight less than 5000, while a protein contain 50 or more amino acids and its molecular weight lies high this value. Many pharmaceutical proteins and peptides are engrossed IM, IV and Subcutaneous routes of Absorption, but the oral route is more appropriate for absorption of protein as collate to others.

Track 11: Therapeutic Drug Carrier Systems

Therapeutic uses of a diverse of drug carrier systems have a compelling effect on the treatment and possible heal of various chronic diseases, including Alzheimer's, Parkinson's, diabetes mellitus, cancer , psoriasis, , rheumatoid arthritis, HIV infection, infectious diseases, asthma, and drug addiction. Scientific attempts in these areas a versatile, including the biological, medical, physical, pharmaceutical, biological materials, and engineering fields. Drug carrier systems are now as important as the drug itself. Controlled release supply extends the delivery of a drug while sustaining its blood concentration within therapeutic limits.

Track 12: Routes of Drug Administration

Advances in drug formulations and inventive routes of administration have been made. Our comprehension of drug transport across tissues has enlarged. These transformation have frequently caused in enhance patient constancy to the therapeutic regimen and pharmacologic response. The administration of drugs by transdermal or transmucosal routes provides the prevalence of being relatively painless. Also, the potential for immense compliance in a variety of clinical situations exists, frequently precluding the obligation to initiate intravenous access, which is a specific assistance for children. This report focuses on the advantages and disadvantages of alternative routes of drug administration. Concerns of specific significance in the protection of pediatric patients, particularly elements that could guide to drug-related toxicity or adverse responses, are emphasized.

Track 13: Pharmaceutical Formulation Technologies

Pharmaceutical formulations are a combination of the pharmaceutically active ingredient and determine inactive ingredients. Solution formulations that are used for injectable dosage forms commonly have some inactive ingredients—such as buffering agents, water, co-solvents, and pH-adjusting agents. As a consequence, they are copious easy to formulate collate to some of the semisolid formulations used for topical administration. A pharmaceutical formulation is made of various formulation factors and process variables. The quantitative model-based pharmaceutical formulation includes initiating mathematical relations enclosed by the formulation variables and the emergency responses and extend the formulation cases.

Track14: Drug Delivery through Blood-Brain Barrier (BBB)

The brain is shielded and segregated from the normal circulation by a highly adequate blood-brain barrier. This is characterized by relatively impermeable endothelial cells with tight junctions, enzymatic activity and active efflux transport systems. Therefore the blood-brain barrier is layout to allow discriminatory carriers of molecules that are important for brain function. This builds an extensive protest for the treatment of central nervous system diseases compelling therapeutic levels of the drug to get into the brain. Some small lipophilic drugs diffuse across the blood-brain barrier- sufficiently well to be efficacious. However, many potentially useful drugs are excluded.

Track 15: Controlled Released Technologies

Controlled drug release and consequent ecological are important for evolving fortunate formulations. The method of delivery can be the variation enclosed by a drug’s accomplishment and failure, as the selection of a drug is frequently persuaded by the way the medicine is administered. Sustained (or continuous) release of a drug includes polymers that deliver the drug at a controlled rate due to dispersion out of the polymer or by degradation of the polymer over time. The pulsatile release is frequently the selected method of drug delivery, as its enclosure mimics the way by which the body generally produces hormones such as insulin. It is accomplished by using drug-carrying polymers that react to particular stimuli (e.g., exposure to light, changes in pH or temperature).

Track 16: Transdermal and Intradermal Drug Delivery Systems

Bioadhesive liposomes contain levonorgestrel as a controlled drug delivery system has been investigated. Mesophasic proliposomal system for levonorgestrel was processed. The vesicles were predominantly unilamellar and some were multilamellar. Deliver was of zero-order kinetics. Alcohol as compared to oils had a tremendous influence on transdermal flux. In vivo studies demonstrate that important lag phase was notice before the therapeutic levels were reached reveal the specification for a loading dose. This pro liposomes system was beginning to be superior to the PEG-based ointment system. The liposomal reservoir system containing local anesthetic benzocaine was evolved for controlled and localized delivery via topical route. The liposomal suspension was included in an ointment and gel base.

Track 17: Drug Delivery system for Bio pharmaceutics

Pharmaceutical biotechnology has been display therapeutic accomplishment never attain with standard drug molecules. Accordingly, biopharmaceutical products are presently well-established in clinic and the evolution of new ones is anticipated. These products comprise mainly therapeutic proteins, although nucleic acids and cells are also included. However, as stated in their sensitive molecular structures, the systematic delivery of biopharmaceuticals is challenging. Various delivery systems (e.g. Microparticles and nanoparticles) made of several materials (e.g. polymers and lipids) have been analysed and determine tremendous outcomes, such as: high cellular transfection ability for nucleic acids, increased proteins, cell targeting, and peptides bioavailability, improved immune response in vaccination, and viability maintenance of microencapsulated cells, Drug implants.

Track 18: Medical Devices for Drug Delivery

Medical devices layout for drug delivery through the pulmonary and nasal routes. These routes are of interest to local delivery, as in asthma, but also for the rapid delivery of drugs to the system circulation and direct delivery to the central nervous system. Devices that report for particular anatomical and physiological features of the intranasal and pulmonary routes will be characterized. Drug delivery devices are specialized tools for the delivery of a drug or therapeutic agent via a particular route of administration. Such devices are used as a bit of one or more medical treatments. Many in the industry have long felt overly laden by what they acknowledge to be an unessential complicated approval process. Critics declare it impedes innovation and detain the opportunity of better health care. In order to help innovators import health care to the public.

Track 19: Business Opportunities in Drug Delivery

The global market for Business Development of Drug Delivery Technology in 2010 was $131.6 billion and is expected to rise at a compound annual growth rate (CAGR) of 5% and reach nearly $175.6 billion by 2016. The U.S constituted approximately 59% of the total drug delivery market in 2010 and was $78 billion. It is forecast to reach nearly $103 billion in 2016 at a CAGR of 4.7%. Europe contributed about 27% of the total drug delivery market in 2010 and was $36 billion and is expected to grow to $49 billion by 2016 at a CAGR of 5.6% in 2013, Drug Delivery Global market reached $150.3 billion, according to BCC research. This was an increase from $142 billion the previous year. Given its predicted annual growth, the market represents a considerable business opportunity, which has been reflected in the increasing number of drug delivery specialists. Consistent quality and competitive costs of the product improves Production performance and continuity of supply and Product and technology auditing and due diligence with minimizing Regulatory Issues, quality control, and business development Business opportunities in drug delivery.

Track 20: Major Challenges in Drug Delivery

There are several biochemical limitations that upset effective drug delivery. Major Challenges in Drug Delivery System involves the delivery of ineffectively dissolvable drugs and bioavailability obstacles for inadequately solvent clinical applicants. Self-emulsifying drug delivery systems (SEDDS) have a supreme potential in increasing the oral bioavailability of poorly water-soluble drugs. There are a few Novel methodologies in the delivery which oversees the bioavailability obstacles and aids in the rationale formulation design of poorly soluble drugs. At present, the interest in non-invasive drug-delivery methods has been increasing. Nowadays, biopharmaceuticals generate a global income of $163 billion, making up about 20 percent of the total pharma market. As of now, it’s the fastest-growing part of the industry. The current annual growth rate of biopharmaceuticals more than 8 percent is double to that of conventional pharma, and is expected to continue in the future as well.

The global pharmaceutical drug delivery market is forecast to reach USD 1,694.7 billion by 2023 from USD 1,244.4 billion in 2018, at a CAGR of 6.4% during the forecast period. The factors carry market growth comprises the increasing generality of chronic diseases, growth in the biologics market, and technological advancements & new product launches. The global pharmaceutical drug delivery market is divided into four major regions, namely, North America, Europe, Asia Pacific, and the remaining of the World. In 2018, North America consider for the largest share of the market. The large share of the North American market can be allocate to elements such as development in biologics in the pharmaceuticals market; the increasing generality of chronic diseases increasing patient conformity to innovative drug delivery technologies; and the existence of a huge number of prominent players in this region.

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	November 19-20, 2021
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed
Poster Opportunity Closed	Click Here to View

Useful Links

Special Issues

All accepted abstracts will be published in respective Our International Journals.

Abstracts will be provided with Digital Object Identifier by

38 ^th International Conference on Drug Discovery and Drug delivery system November 19-20, 2021 Chicago, USA

Recommended Global Pharmaceutical Sciences Conferences

USA & Americas

Europe & Middle East

Asia Pacific

Meet Inspiring Speakers and Experts at our 1000+ Global Events inclusive of 300+ Conferences, 500+ Workshops and 200+ Symposiums Every year on Medical, Pharma, Engineering, Science, Technology and Business.

For more Conferences visit www.conferenceseries.com

Quick Links

Drug Delivery 2021

Conference Highlights

To Collaborate Scientific Professionals around the World

Useful Links

Special Issues